BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28798348)

  • 1. Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection.
    Malyshkina A; Littwitz-Salomon E; Sutter K; Zelinskyy G; Windmann S; Schimmer S; Paschen A; Streeck H; Hasenkrug KJ; Dittmer U
    Sci Rep; 2017 Aug; 7(1):7785. PubMed ID: 28798348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
    Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
    Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
    J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice.
    Peterson KE; Stromnes I; Messer R; Hasenkrug K; Chesebro B
    J Virol; 2002 Aug; 76(16):7942-8. PubMed ID: 12133998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.
    Peterson KE; Iwashiro M; Hasenkrug KJ; Chesebro B
    J Virol; 2000 Jun; 74(11):5363-7. PubMed ID: 10799615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement for CD4(+) T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery mice.
    Super HJ; Brooks D; Hasenkrug K; Chesebro B
    J Virol; 1998 Nov; 72(11):9400-3. PubMed ID: 9765497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection.
    Zelinskyy G; Kraft AR; Schimmer S; Arndt T; Dittmer U
    Eur J Immunol; 2006 Oct; 36(10):2658-70. PubMed ID: 16981182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race between retroviral spread and CD4+ T-cell response determines the outcome of acute Friend virus infection.
    Pike R; Filby A; Ploquin MJ; Eksmond U; Marques R; Antunes I; Hasenkrug K; Kassiotis G
    J Virol; 2009 Nov; 83(21):11211-22. PubMed ID: 19692462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
    Sugahara D; Tsuji-Kawahara S; Miyazawa M
    J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Friend Virus Infection and Regulatory T Cells on the Antigen Presentation Function of B Cells.
    Moore TC; Messer RJ; Gonzaga LM; Mather JM; Carmody AB; Bayer W; Littwitz-Salomon E; Dittmer U; Hasenkrug KJ
    mBio; 2019 Jan; 10(1):. PubMed ID: 30670616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.
    Knuschke T; Rotan O; Bayer W; Sokolova V; Hansen W; Sparwasser T; Dittmer U; Epple M; Buer J; Westendorf AM
    Retrovirology; 2016 Apr; 13():24. PubMed ID: 27076190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance.
    Malyshkina A; Littwitz-Salomon E; Sutter K; Ross JA; Paschen A; Windmann S; Schimmer S; Dittmer U
    Cancer Immunol Immunother; 2019 Mar; 68(3):479-488. PubMed ID: 30635687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3.
    Gibbert K; Francois S; Sigmund AM; Harper MS; Barrett BS; Kirchning CJ; Lu M; Santiago ML; Dittmer U
    Retrovirology; 2014 Dec; 11():126. PubMed ID: 25539593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocytic myeloid-derived suppressor cells suppress virus-specific CD8
    Drabczyk-Pluta M; Werner T; Hoffmann D; Leng Q; Chen L; Dittmer U; Zelinskyy G
    Retrovirology; 2017 Aug; 14(1):42. PubMed ID: 28835242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
    Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
    Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune control and prevention of chronic Friend retrovirus infection.
    Hasenkrug KJ; Dittmer U
    Front Biosci; 2007 Jan; 12():1544-51. PubMed ID: 17127401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cells develop antiretroviral cytotoxic activity in the absence of regulatory T cells and CD8+ T cells.
    Manzke N; Akhmetzyanova I; Hasenkrug KJ; Trilling M; Zelinskyy G; Dittmer U
    J Virol; 2013 Jun; 87(11):6306-13. PubMed ID: 23536666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of B Cell Follicle-Resident Cells by Friend Retrovirus Occurs during Acute Infection and Is Maintained during Viral Persistence.
    Windmann S; Otto L; Hrycak CP; Malyshkina A; Bongard N; David P; Gunzer M; Dittmer U; Bayer W
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice.
    Hasenkrug KJ
    J Virol; 1999 Aug; 73(8):6468-73. PubMed ID: 10400741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.